Novagold Resources Inc. vs Oscar Health Inc — how do they compare? Novagold Resources Inc. trades at $6.32 (market cap $2.90B), while Oscar Health Inc trades at $34.17 (market cap $10.43B). The key difference: Oscar Health Inc is far larger — about 3.6× Novagold Resources Inc.'s market cap, and Oscar Health Inc is trading nearer its 52-week high, Novagold Resources Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Novagold Resources Inc. for 0 Days and Oscar Health Inc for 15 Days on average.
| NG | OSCR | |
|---|---|---|
Market Cap | $2.90B | $10.43B |
Volume | 3,973,464 | 5,467,402 |
Sector | Basic Materials | Health |
52-Week High | $14.20 | $34.32 |
52-Week Low | $5.18 | $10.85 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $2.74B | $6.79B |
Signals from Pluang's Aura AI — not financial advice
NovaGold Resources (NG) trades at $6.63, down 1.49% today, as the company navigates its development phase for the Donlin Gold project. The stock shows mixed earnings performance with recent quarterly losses but beats expectations in two of the last four quarters. Financials reveal negative profitability metrics with ROE at -32.81% and net income of -$94.66M for 2025, though cash flow remains positive due to financing activities. Recent news highlights the company's move to acquire full ownership of Donlin Gold, a major Alaska gold project.
The outlook for NG hinges on successful development of Donlin Gold, with 100% analyst buy ratings signaling strong Wall Street confidence. However, significant execution risks exist given negative earnings and substantial capital requirements. Investors face volatility from gold price fluctuations and project development timelines, making this suitable for those with high risk tolerance seeking exposure to a major gold development story.
OSCR trades at $33.79, down 0.65% on the day, with strong technical momentum indicated by bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent analyst upgrades to Strong Buy reflect optimism about expanded market opportunities and margin expansion potential.
The stock presents growth potential with consensus price target of $34.75 offering modest upside. Key risks include rising medical costs threatening profitability and competitive ACA market pressures. Institutional interest remains strong with recent purchases, supporting the bullish technical outlook despite RSI indicating potential near-term overbought conditions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NovaGold Resources Inc. is a mineral exploration and development company that holds a majority interest in the Donlin Gold project, an undeveloped gold deposit in Alaska.
Read more on NG →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →